Cathie's Ark Logo
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Maxinomics Icon
Manufacturing is Coming Back to the US 🏗️
Date
Direction
Shares
Fund Weight
Fund
February 15, 2024
BUY21.877k0.0075%ARKK
February 13, 2024
BUY76.721k0.0244%ARKK
February 8, 2024
BUY27.104k0.0093%ARKK
February 6, 2024
BUY600.0000.0002%ARKK
February 5, 2024
BUY102.213k0.0324%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
2.66%$2.62b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
14🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
16$62.04
🎫ARK Ownership Percent
8.08%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA